Across the recent three months, 7 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Analysts’ evaluations of 12-month price targets offer additional insights, showcasing an average target of $80.43, with a high estimate of $93.00 and a low estimate of $77.00. This upward trend is evident, with the current average reflecting a 6.43% increase from th…